Medi First Plus PMS Relief 500 mg/1
Acetaminophen, Pamabrom, Pyrilamine maleate · TABLET, COATED · Unifirst First Aid Corporation
Medi First Plus PMS Relief is a tablet, coated containing acetaminophen, pamabrom, pyrilamine maleate at 500 mg/1, taken oral. Manufactured by Unifirst First Aid Corporation.
Key Facts
- Brand Name
- Medi First Plus PMS Relief
- Generic Name
- Acetaminophen, Pamabrom, Pyrilamine maleate
- NDC Code (Product)
47682-723- Manufacturer
- Unifirst First Aid Corporation
- Strength
- 500 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- Application #
- M027
- Marketing Start
- 09/26/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Medi First Plus PMS Relief used for?
Medi First Plus PMS Relief contains Acetaminophen, Pamabrom, Pyrilamine maleate. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is Medi First Plus PMS Relief a controlled substance?
Medi First Plus PMS Relief is not classified as a controlled substance by the DEA.
What is the generic name for Medi First Plus PMS Relief?
The generic name for Medi First Plus PMS Relief is Acetaminophen, Pamabrom, Pyrilamine maleate. There are 12 other brand versions of Acetaminophen, Pamabrom, Pyrilamine maleate.
What is the NDC code for Medi First Plus PMS Relief 500 mg/1?
The NDC (National Drug Code) for Medi First Plus PMS Relief 500 mg/1 is 47682-723, listed by Unifirst First Aid Corporation.
Other Acetaminophen, Brands
See all →- Medi First PMS Relief500 mg/147682-823
- Menstrual Relief Maximum Strength500 mg/155319-979
- PMS Relief Maximum Strength500 mg/159779-879
- Menstrual Relief Maximum Strength Multi Symptom500 mg/170000-0145
- Thompson Cramp Relief500 mg/173408-923
- Menstrual Relief Maximum Strength500 mg/155301-679
- Menstrual Relief Maximum Strength500 mg/136800-979
- Menstrual Relief Maximum Strength500 mg/150844-679
- Menstrual Pain Relief500 mg/183324-057
- menstrual pain relief maximum strength500 mg/111822-6790
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)